Shriram Finance Limited (SHRIRAMFIN.NS)
Mumbai, TN, IN
Shriram Finance Limited, a non-banking finance company, provides financing services in India. It offers fixed and recurring deposits; commercial vehicle loans for commercial goods vehicles, passenger commercial vehicles, tractors and farm equipment, and construction equipment; two-wheeler, gold, used car loan, and personal loans; and green finance services. The company also provides business loans, such as MSME loans; working capital loans, including tyre, tax, fuel, toll financing, repair/top-up loans, fuel finance, and challan discounting; motor insurance, including four-wheeler, two-wheeler, passenger and goods carrying vehicle insurance products; non motor insurance products, such as personal accident, shri criti care, and home insurance; and life insurance products comprising savings, retirement, child, protection plans, as well as recharges, including mobile recharge, mobile postpaid, landline postpaid, DTH, and FASTag recharge services. In addition, it offers utilities and bills payment services, such as electricity, LPG gas, gas, broadband postpaid, water, and cable tv; financial services and taxes comprising credit card, loan repayment, insurance, municipal services, and recurring deposit; and other services, such as hospital and pathology, housing society, clubs and associations, and education fees. It serves first time buyers, small road transport operators, individuals, micro, small, and medium enterprises (MSMEs), salaried professionals, and self-employed individuals. The company was formerly known as Shriram Transport Finance Company Limited and changed its name to Shriram Finance Limited in November 2022. Shriram Finance Limited was incorporated in 1979 and is based in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.75% | +5.06% | +3.74% | -4.85% | +12.61% | -4.14% | +43.14% | +230.80% | +223.27% | +322.77% | +95,993.66% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 7 | 0 |
| Buy | 23 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth+19.9% Q1'26: +17.7% (vs Q1'25)
-
EPS growth+29.7% Q1'26: +40.9% (vs Q1'25)
-
FCF margin-163.6% Q1'26: -34.3% (vs Q1'25)
-
EBIT margin+30.8% Q1'26: +31.3% (vs Q1'25)
-
ROIC+4.4% Q1'26: +5.1% (vs Q1'25)
-
Share dilution+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA13.55× Q1'26: 11.05× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 26 Rev. Ana. 28 EPS Ana. |
Mar 2027 27 Rev. Ana. 31 EPS Ana. |
Mar 2028 27 Rev. Ana. 31 EPS Ana. |
Mar 2029 20 Rev. Ana. 24 EPS Ana. |
Mar 2030 13 Rev. Ana. 14 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
88.85B
est: 42.71B (+108.0%)
|
103.03B
est: 50.48B (+104.1%)
|
108.47B
est: 57.08B (+90.0%)
|
133.88B
est: 67.15B (+99.4%)
|
154.68B
est: 80.10B (+93.1%)
|
164.07B
est: 83.62B (+96.2%)
|
166.83B
est: 84.00B (+98.6%)
|
192.88B
est: 92.67B (+108.1%)
|
298.62B
est: 170.92B (+74.7%)
|
338.86B
est: 200.44B (+69.1%)
|
406.43B
est: 233.92B (+73.7%)
|
266.79B
258.57B – 278.01B
+14.1% YoY
|
333.53B
316.50B – 357.80B
+25.0% YoY
|
398.49B
366.50B – 431.22B
+19.5% YoY
|
464.06B
432.99B – 500.21B
+16.5% YoY
|
550.20B
513.36B – 593.05B
+18.6% YoY
|
| EBITDA |
16.93B
est: 11.25B (+50.5%)
|
18.27B
est: 13.30B (+37.4%)
|
19.73B
est: 15.04B (+31.2%)
|
39.33B
est: 17.69B (+122.3%)
|
38.21B
est: 21.10B (+81.1%)
|
35.80B
est: 22.02B (+62.5%)
|
34.15B
est: 22.13B (+54.4%)
|
36.85B
est: 24.41B (+50.9%)
|
88.14B
est: 45.02B (+95.8%)
|
102.52B
est: 52.80B (+94.2%)
|
131.48B
est: 65.64B (+100.3%)
|
74.87B
72.56B – 78.02B
+14.1% YoY
|
93.60B
88.82B – 100.41B
+25.0% YoY
|
111.83B
102.85B – 121.02B
+19.5% YoY
|
130.23B
121.51B – 140.37B
+16.5% YoY
|
154.41B
144.07B – 166.43B
+18.6% YoY
|
| EBIT |
16.50B
est: 10.67B (+54.6%)
|
17.89B
est: 12.61B (+41.9%)
|
19.38B
est: 14.26B (+35.9%)
|
38.96B
est: 16.77B (+132.2%)
|
37.78B
est: 20.01B (+88.8%)
|
34.39B
est: 20.89B (+64.6%)
|
32.78B
est: 20.98B (+56.2%)
|
35.49B
est: 23.15B (+53.3%)
|
82.14B
est: 42.69B (+92.4%)
|
96.84B
est: 50.07B (+93.4%)
|
125.03B
est: 62.17B (+101.1%)
|
70.91B
68.72B – 73.89B
+14.1% YoY
|
88.64B
84.12B – 95.09B
+25.0% YoY
|
105.91B
97.41B – 114.61B
+19.5% YoY
|
123.34B
115.08B – 132.94B
+16.5% YoY
|
146.23B
136.44B – 157.62B
+18.6% YoY
|
| Net Income |
10.28B
est: 104.21B (-90.1%)
|
11.84B
est: 21.78B (-45.7%)
|
12.66B
est: 23.37B (-45.8%)
|
25.49B
est: 28.99B (-12.1%)
|
25.76B
est: 38.59B (-33.3%)
|
25.12B
est: 48.24B (-47.9%)
|
24.99B
est: 37.31B (-33.0%)
|
27.21B
est: 35.89B (-24.2%)
|
60.11B
est: 63.53B (-5.4%)
|
73.66B
est: 72.29B (+1.9%)
|
95.54B
est: 90.68B (+5.4%)
|
91.69B
83.71B – 96.01B
+1.1% YoY
|
107.58B
98.22B – 119.57B
+17.3% YoY
|
130.95B
123.63B – 146.38B
+21.7% YoY
|
154.51B
141.06B – 170.15B
+18.0% YoY
|
169.05B
154.33B – 186.16B
+9.4% YoY
|
| SGA |
2.67B
est: 591.47M (+351.9%)
|
1.65B
est: 699.10M (+136.0%)
|
2.20B
est: 790.57M (+178.7%)
|
1.36B
est: 929.99M (+46.4%)
|
1.07B
est: 1.11B (-3.5%)
|
1.21B
est: 1.16B (+4.7%)
|
1.74B
est: 1.16B (+49.3%)
|
11.03B
est: 1.28B (+759.1%)
|
28.70B
est: 2.37B (+1,112.3%)
|
35.50B
est: 2.78B (+1,178.8%)
|
41.56B
est: 16.85B (+146.6%)
|
19.22B
18.63B – 20.03B
+14.1% YoY
|
24.03B
22.80B – 25.78B
+25.0% YoY
|
28.71B
26.41B – 31.07B
+19.5% YoY
|
33.44B
31.20B – 36.04B
+16.5% YoY
|
39.64B
36.99B – 42.73B
+18.6% YoY
|
| EPS |
8.83
est: 55.36 (-84.0%)
|
10.17
est: 11.57 (-12.1%)
|
10.87
est: 12.41 (-12.4%)
|
21.89
est: 15.40 (+42.1%)
|
22.12
est: 20.50 (+7.9%)
|
21.58
est: 25.62 (-15.8%)
|
20.29
est: 19.82 (+2.4%)
|
20.44
est: 19.07 (+7.2%)
|
32.11
est: 33.75 (-4.9%)
|
39.18
est: 38.40 (+2.0%)
|
50.82
est: 48.17 (+5.5%)
|
48.71
44.47 – 51.00
+1.1% YoY
|
57.15
52.17 – 63.52
+17.3% YoY
|
69.56
65.67 – 77.76
+21.7% YoY
|
82.08
74.93 – 90.39
+18.0% YoY
|
89.80
81.98 – 98.89
+9.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-10 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-09 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-08 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-05 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-04 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-03 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-02 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-06-01 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-10 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Umesh Govind Revankar | Executive Vice Chairman | 24M | male |
| Parag Sharma | MD, CEO & Whole-Time Director | 15M | male |
| Gouse Mohiddi Jilani | Joint MD & Chief Operating Officer | — | male |
| Hardeep Singh Tur | Chief Risk Officer | — | male |
| Nilesh Odedara | Joint MD& Chief Sales Officer | — | male |
| A. Ganesh | President & Chief Human Resources Officer | — | male |
| Sanjay K. Mundra | Executive Director of Investor Relations | — | male |
| Sudarshan Holla | Joint MD & Chief Operating Officer | — | male |
| Sunder Subramanian | Joint Managing Director, CFO & Whole Time Director | — | male |
| Balasundararao Uppu | Company Secretary & Compliance officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SHRIRAMFIN.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
